ISA Pharmaceuticals

ISA Pharmaceuticals is an immunotherapy company. It develops synthetic immunotherapeutics against cancer and persistent virus infections. The company builds an immunotherapy platform based on its Synthetic Long Peptide (SLP) concept and its AMPLIVANT technology. SLP immunotherapies are designed to direct the body’s own defense mechanisms towards fighting the disease, either alone or in combination with existing therapies.